Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05182632

Tele-rehabilitation Group Program for Urinary Incontinence in Older Women

Feasibility, Acceptability and Effects of a Tele-rehabilitation Pelvic Floor Muscle Training Group Program for Urinary Incontinence in Older Women

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
32 (estimated)
Sponsor
Université de Montréal · Academic / Other
Sex
Female
Age
65 Years
Healthy volunteers
Not accepted

Summary

The recommended treatment for urinary incontinence (UI) in women is individualized pelvic floor muscle training (PFMT), a costly and resource-intensive approach; one Canada is currently unable to meet. A recent non-inferiority randomized controlled trial just confirmed that group-based PFMT is equally effective but less resource-intensive (more cost-effective) than individual PFMT to treat UI in older women (ClinicalTrials.gov Identifier: NCT02039830). In times of COVID-19 however, with the Quebec, Canada's public health authorities preventing gatherings to stop the virus' spread, the potential of in-person group approaches is temporarily limited. It is thus important to develop innovative ways to deliver this first-line treatment remotely, particularly for those confined at home for whom UI can have a detrimental impact on physical health and quality of life. Ensuring an online option for group-based PFMT would also allow to increase the accessibility of UI treatment for women living in rural or remote areas in Canada, where pelvic floor rehabilitation services are not available or scarce. To this end, this study will assess the feasibility, acceptability and effects of a tele-rehabilitation PFMT group program for UI in older women.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGroup pelvic floor telerehabilitationMultimodal group physiotherapy: 12 weeks of weekly group physiotherapy treatments including education and pelvic floor muscle exercises delivered online + home exercise program

Timeline

Start date
2021-03-06
Primary completion
2022-04-06
Completion
2026-04-06
First posted
2022-01-10
Last updated
2025-04-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05182632. Inclusion in this directory is not an endorsement.